Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
L01EA04	BOSULIF	B	Bosutinib - 500mg	500mg	Tablet, film coated	154,453,246 L.L
N06AA09	TRYPTIZOL	B	Amitryptiline (HCl) - 25mg	25mg	Tablet, coated	716,716 L.L
R01AA07	OTRIVIN MENTHOL 0.1%	B	Xylometazoline HCl - 0.1%	0.1%	Drops	387,027 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 1%	1%	Drops	170,668 L.L
A06AB58	PICOPREP	B	Magnesium oxide - 3.5g, Citric acid - 12g, Sodium picosulfate - 10mg		Powder	694,767 L.L
A10BD20	SYNJARDY	B	Empagliflozin - 12.5mg, Metformin HCl - 1000mg	12.5mg/1000mg	Tablet, film coated	3,156,820 L.L
B01AF01	XARELTO	B	Rivaroxaban - 15mg	15mg	Tablet, film coated	4,440,862 L.L
C01EB18	RANEXA	B	Ranolazine - 500mg	500mg	Tablet, prolonged release	3,985,837 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Cream	279,519 L.L
L01EA05	ICLUSIG	B	Ponatinib - 15mg	15mg	Tablet, film coated	103,555,839 L.L
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
C01EB18	RANEXA	B	Ranolazine - 750mg	750mg	Tablet, prolonged release	3,985,837 L.L
C09BA04	BI-PRETERAX ARGININE	B	Perindopril arginine - 5mg, Indapamide - 1.25mg		Tablet, film coated	452,875 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	542,912 L.L
L01EA05	ICLUSIG	B	Ponatinib - 45mg	45mg	Tablet, film coated	207,092,651 L.L
R06AE07	ZYRTEC	B	Cetirizine (dihydrochloride) - 5mg/5ml		Solution	278,175 L.L
J01CR05	PIPERACILLINE/ TAZOBACTAM ARROW		Piperacillin (sodium) - 4g, Tazobactam (sodium) - 500mg			7,378,682 L.L
J01CR05	TAZOBACT		Piperacillin sodium - 4g, Tazobactam (sodium) - 500mg			783,460 L.L
N02BE51	PARACETAMOL/CAFEINE/CODEINE BIOGARAN		Paracetamol - 400mg, Caffeine - 50mg, Codeine - 20mg			548,288 L.L
D06AX	TRIPLE ANTIBIOTIC ORIGINAL OINTMENT		Bacitracin - 400U, Neomycin (sulfate) - 3.5mg, Polymyxin B (sulfate) - 5000U			580,540 L.L